Insights

Casual Nexus – Episode One: Formulation Development and Clinical Supply of Aseptic Liposomal

icons/content-types/video webinar

Drug Product

Presenters: Iain MacGilp, Ph.D., Director, GMP Production, Curia Amber McFarlane, Head of Formulation Development, Curia Listen in as our experts discuss: The importance of an integrated formulation development and clinical supply function that can support accelerated timelines to clinic, including complex formulations Recent and ongoing experiences in liposomal formulations, with focus on high pressure homogenization Linearity of laboratory to clinical supply scale-up with supporting analytics Broad applicability to variety of product types and presentations (liquid, lyophilized, potent compounds, cytotoxics

View resource 0088AE5F-29AA-4BF7-826D-52FA93D463D0

Ready to move from idea to impact?

Whether you have a question for our team or an opportunity you’re eager to pursue, one of our experts can help you get started.

Contact Us
More from Curia

icons/content-types/video webinar

Antibody-Drug Conjugate (ADC) – From Bioassay Development to Linker-Payload Constructs

In this webinar, we will discuss select examples of Curia’s experience in the ADC discovery space and how some of these challenges are overcome.

icons/content-types/article article

Accelerating Therapies With Curia From Conception to Manufacturing

Partnering with a CDMO can help streamline drug development, and certain preparations can help ensure a successful collaboration. Scott Alderucci, Curia’s Director of Process Development, explores the advantages of partnering with a CDMO to navigat...